Organización Sanitaria Integrada Bilbao-Basurto
Organización de Osakidetza
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Médica Aplicada (12)
2023
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
-
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
Blood Advances, Vol. 7, Núm. 1, pp. 167-173
2021
-
Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases
Neurological Sciences, Vol. 42, Núm. 4, pp. 1473-1482
2020
-
CAV-2-Mediated GFP and LRRK2G2019S Expression in the Macaca fascicularis Brain
Frontiers in Molecular Neuroscience, Vol. 13
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2019
-
Amylin as a potential link between type 2 diabetes and alzheimer disease
Annals of Neurology, Vol. 86, Núm. 4, pp. 539-551
-
Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease
Clinical Autonomic Research, Vol. 29, Núm. 4, pp. 415-425
2018
-
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
Acta Neuropathologica, Vol. 135, Núm. 6, pp. 877-886
2017
-
Effect of dexmedetomidine and propofol on basal ganglia activity in Parkinson disease a controlled clinical trial
Anesthesiology, Vol. 126, Núm. 6, pp. 1033-1042
2016
-
Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems
Maturitas, Vol. 84, pp. 25-31
-
Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys
Biomaterials, Vol. 110, pp. 11-23
2007
-
DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups
Leukemia, Vol. 21, Núm. 6, pp. 1224-1231